Fountain TRT Reviews: Full-Year Billing and Refunds (2026)

Fountain can fit cash-pay adults who want remote care, but its $199 Starter plan bills every four weeks, not monthly. These Fountain TRT reviews compare the annual math with its refund terms. Confirm state access, repeat testing, medication and pharmacy before paying; near-term fertility plans call for specialist advice first.

By TRT Provider Guide · Last verified: September 2026 (public sources checked September 14, 2026) Public-source provider profile and cost guide. Not a patient treatment review; not medically reviewed.

Educational information, not medical advice. This page concerns adult men evaluating testosterone deficiency, not gender-affirming care, treatment for women or adolescents, or performance use.

Best for: comparing a cash-pay online evaluation and bundled care after the missing terms are settled. Not for you if: near-term fertility needs, complex health concerns, or insurance coverage call for another starting point.

These are Fountain's advertised base plans, not complete first-year quotes. The Endocrine Society guideline supports the fertility and diagnostic limits in the opening answer.

Disclosure: Male Excel is a commercial partner of TRT Provider Guide. The Fountain and Male Excel links on this page are direct public-information links, not affiliate enrollment links. See our affiliate disclosure.

---

Fountain's Starter price is $199 per four weeks. That number is real. It is also not what a year costs, and the gap is bigger than you'd guess.

Fountain bills every four weeks, not every month. Thirteen Starter cycles buy 364 days of base service and cost $2,587. With the first charge on day 0 and uninterrupted renewal, fourteen charges land inside the next 365 days — $2,786 on your card before the anniversary. That's our calculation from the published intervals, not an all-in quote.

The plan that looks cheapest is the one that hits hardest up front. We'll show you the calendar in a minute.

What changes this answer: your state (we did not verify a complete current coverage list), your lab (Fountain qualifies included monitoring with "except where prohibited by state law"), your plan (the 48-week plan is not a year), and whether low testosterone has actually been confirmed yet. That last one comes before committing to treatment, though a provider can help with the evaluation. Sources: Fountain membership inclusions, diagnostic guidance.

We read Fountain's program pages, its Terms of Use, its Return Policy and its telehealth consent form on the same day, plus its Trustpilot profile and the current federal rules. Two live Fountain pages give different refund answers. Before a $1,799 prepayment, that's worth settling in writing. The older terms and the Return Policy linked from fountain.net are compared below.

---

Best for / not for you

A reasonable fit if you:

• Want a bundled price for medication, shipping, provider visits and support, after confirming how the lab exception applies
• Prefer a cream or an injection and want to discuss both with the clinician; confirm the price for the actual prescription
• Are willing to get the exact product, strength and pharmacy in writing rather than relying on the public plan card
• Live in a state Fountain confirms it can serve while you are physically there

Start somewhere else if you:

• Want children in the next few years — testosterone can suppress sperm production, and that conversation belongs with a urologist or reproductive urologist first
• Have never had low testosterone confirmed properly — start with a clinical evaluation and appropriate repeat early-morning testing, not a prepaid treatment commitment
• Need insurance to pay, or need a confirmed FDA-approved product and pharmacy path that Fountain has not established for you
• Have a prostate or breast cancer history, a high red blood cell count, untreated severe sleep apnea, or a recent heart attack or stroke — discuss the appropriate setting with your usual clinician or specialist first

These are care-route judgments, not a diagnosis or a blanket ban on all future treatment. Source: Endocrine Society recommendations.

---

What we actually verified

We checked public pages and policies on September 14, 2026, and calculated every cost figure below from the providers' published plan terms. Our math is labeled as ours. Reading a promise verifies what the provider publishes, not how every patient is treated.

What we could not confirm, and won't pretend we did: a complete current list of states Fountain serves · the exact medication product, strength and dispensing pharmacy for a patient · the current price of the initial evaluation · the method behind Fountain's advertised 213% average increase · any lab surcharge schedule · a universal repeat-test, refill or monitoring timetable.

What we did not do: we did not buy treatment, contact support, test a cancellation, verify an individual clinician's license, or review anyone's medical records. This page has not been medically reviewed.

---

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

---

What do Fountain TRT reviews actually say?

Fountain TRT holds 4.4 stars from 316 Trustpilot reviews as of September 14, 2026, with 57 posted in the previous twelve months. Reviews can show you service experiences — billing, scheduling, communication — but they cannot tell you whether treatment is medically right for you, and a few visible reviews are not a measure of how often anything happens.

The distribution is unusual: 94% are five-star and 6% are one-star, with almost nothing in between. Trustpilot also shows under 1% each for four- and two-star reviews and zero three-star reviews; these are rounded percentages, not exact counts. Source: FountainTRT on Trustpilot.

The praise is specific, and it's mostly about the same thing

People like the texting. Positive reports in the pages we inspected describe quick replies, help with labs and clear explanations. Those are service experiences worth reading, not a measured response-time guarantee. Source: current Trustpilot reviews.

One review addresses a useful concern, and it isn't a before-and-after story. Michael Bullis, posting on August 13, 2026, wrote that Fountain "won't sell you something you don't need" and said he was told his testosterone was healthy. That is his account; it does not establish a prescribing policy or prove what every clinician would do. Source: his review on FountainTRT's profile.

Grant Pallan, posting on July 31, 2026, said after doing his homework that the service was "transparent and exactly as advertised including pricing." Source: his review on FountainTRT's profile.

The complaints raise five practical questions

We inspected the first two review pages, including the negative reports visible there. These are selected individual accounts, not a full review census, verified patient records, or complaint-frequency data.

Sources: Trustpilot page 1 and page 2.

One reviewer did report a missing refill. The useful questions are about billing, scheduling, continuity, delivery and cancellation — not just whether a company has a clinician. Ask about those in advance, and keep the written answers.

Two numbers worth knowing before you trust any rating

Fountain's program page advertises a 4.9 TrustScore. Trustpilot's live FountainTRT profile shows 4.4. The claim of more than 200 five-star reviews is consistent with the profile's rounded distribution, but the displayed scores do not match. Sources: Fountain's program page, Trustpilot.

That isn't proof of a scandal. It is a reason to use a dated source for the score and written confirmation for the terms that affect your purchase.

Trustpilot also flags two things on the profile itself: Fountain hasn't invited customers to review recently, so the sample may not be representative, and it hasn't replied to negative reviews. Neither is damning. Both are worth weighing. These are the platform's statements at the time checked, not our audit of customer correspondence. Source: Trustpilot profile notices.

We won't quote a single results testimonial here — not from Trustpilot, not from Fountain's own page. Someone else's energy, weight or sex life is not evidence about yours, and using it that way is how this category gets in trouble.

---

How much does Fountain TRT cost for a full year?

Fountain publishes three plans, and all three are priced in four-week blocks — not calendar months. A 365-day year holds thirteen complete four-week cycles plus one day. Longer prepayment lowers the rate per week but can raise the cash paid before the first anniversary. Source: published plans.

What Fountain publishes

Rates calculated from the full charge and interval, with rounding only at the end.

Credit where it's due: Fountain's advertised dollar savings are exact. It shows the Standard plan against a $597 list price — that really is 3 × $199, and the stated $98 saving is correct to the dollar. The Pro plan shows against $2,388, which really is 12 × $199, and the $589 saving is right too. These compare equal periods of service, not calendar years. Source: plan cards.

Two different "annual costs," and you need both

A service-rate comparison and a payment calendar are measuring different things.

What the base service costs at the published rate — divide the charge by the days it covers, then multiply by the comparison period. Thirteen four-week cycles are 364 days; a full-year comparison here uses 365. What actually leaves your bank account — count the whole charges that land inside your first 365 days.

Our calculation, from the published plan terms above. These are base-service models, not complete first-year quotes or refund formulas.

The model includes a first payment on day 0 and every renewal before day 365, with unchanged prices and no cancellation. Normalized amounts spread a plan's rate across time; they are not payment options sold by Fountain.

For example, Starter's normalized figure is $199 × 365 ÷ 28 = $2,594.11. Its cash figure is 14 × $199 = $2,786. Use your actual first charge date and renewal terms to build your own payment calendar.

Read that Pro row again. The plan with the lowest weekly rate requires the most cash before your first anniversary — by a wide margin.

That isn't a hidden fee and it isn't a penalty. In this model, the extra money prepays service beyond the twelve-month mark. But if you're budgeting a year, "the cheapest plan" and "the plan that costs me least this year" are not the same sentence.

Why the renewal shows up early

A 48-week plan renews on day 336. Our year model is 365 days. So the second charge lands almost a month before that anniversary.

Using a September 14, 2026 start as an example:

Assumes the first charge on day 0, no cancellation, no price change, and the same interval throughout. Confirm your actual first billing date at checkout — it may not be the day you start treatment.

That's the whole trick, and there's no trick to it. Four weeks is not a month. Thirteen payments buy 364 days of Starter service, and the fourteenth falls on day 364 if renewal continues — two more payments than a twelve-payment budget.

One small thing worth flagging: Fountain's older website still describes its $199 plan as costing less than $7 a day and uses monthly language. At the current 28-day interval, $199 works out to $7.11 a day. Do not mix the old site's calendar wording with the current plan's billing interval.

What the price does and doesn't include

Included, per Fountain's current statement: the medication, shipping, provider video visits, concierge support, and required lab monitoring — the last one qualified by a state-law exception. Source: Fountain membership statement.

Separate or not established: the initial evaluation price; any repeat diagnostic test or state-specific lab bill; at-home lab collection, which Fountain calls an upgrade; and the price treatment of add-ons such as anastrozole or tadalafil. A reviewer reported a $35 evaluation, but that is not a current quote. We did not verify which of these items would add a charge to your plan. Sources: Fountain program details, attributable billing report.

Until you have those in writing for your state, the base-plan model is not a true all-in first-year number. Add the initial evaluation, any required extra tests, collection fees, supplies or add-ons to the payment calendar before choosing a plan. For the wider budget checklist, see our TRT cost guide.

Ready to check the current plans? Fountain's program page shows the live plan cards and billing intervals. Read the interval on each card, not just the rate. → See Fountain's current plans and billing intervals (direct public-information link, not an affiliate enrollment link)

---

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay. (Educational and non-diagnostic.)

---

Can you cancel Fountain TRT, and can you get your money back?

Fountain's published policy permits cancellation by text or email, and its terms say the account closes at the end of the current billing period. Getting money back is a separate question with a different answer. The Return Policy excludes received treatment and medication shipments but allows a pro-rated refund for remaining prepaid future months. Sources: Return Policy, Terms of Use §15–17.

That last sentence matters more than anything else in this section, because another live Fountain page says the opposite.

Three documents, one question

The fountain.net Terms of Use say they cover both fountain.net and fountaintrt.com and link to the Return Policy. That is a reason to ask which terms apply to your purchase, not proof that one document will govern every dispute. The older page saying nothing is refundable is still live.

The correction worth knowing

A blanket statement that Fountain never refunds unused prepaid months does not match the Return Policy linked from fountain.net. A blanket promise that every unused dollar will come back also goes beyond it: the policy does not publish a detailed calculation or processing deadline.

On a $1,799 decision, that's not a technicality.

Both pages are live today. That's exactly the problem. Here are both, so you can check us: the older fountaintrt.com terms and the current Return Policy.

Because the contradiction is live, get the pro-rata term confirmed in writing before you prepay. One message. Save the reply.

The evaluation guarantee is narrower than a change-of-mind refund

Fountain advertises a money-back guarantee tied to the evaluation when a person is not qualified for treatment. Its Return Policy ties refunds to that evaluation guarantee. It does not promise a refund whenever an applicant changes their mind. Sources: program guarantee, Return Policy.

Changing your mind is not the same as being medically declined. Know which one the guarantee covers before you click.

If you do cancel, ask for these five things in writing

1. The date of my last charge
2. The date my service ends
3. Written confirmation that renewal is stopped
4. The remaining prepaid balance you consider eligible, and how you calculated it
5. How to request a copy of my medical records

And one thing that isn't a billing question: cancelling a subscription is not a plan for stopping a medication. If you're on testosterone, stopping is a clinical decision. Talk to the prescriber.

Before you enter a card, get a written quote. Ask for the first charge date, the renewal date and amount, which lab you'll use and who bills it, and what a cancellation refunds. Getting that in one message is the single highest-value thing you can do today. → Ask Fountain for a written quote (this starts a contact request — it isn't an instant quote or an approval)

---

Is Fountain TRT legit, and who actually treats you?

Fountain publishes an operating entity, a Jacksonville address and named medical-practice partners, along with a blood-test and video-visit process. That supports an identifiable telehealth business, not a blanket safety endorsement or a license check of your treating clinician. What it isn't is a single doctor's office — and its own terms say so in a sentence worth reading twice. Sources: Fountain terms, program process.

The platform is not the doctor

Fountain's Terms of Use state: "There is no single provider of medical care called 'Fountain.'" Fountain Vitality provides administrative and payment services. The terms name independent practices — Duval Medical, P.A., Quaker Ridge Medical, PLLC, Avalon Medical, PC and Redwood Medical, PC. Source: Terms of Use.

A platform and a medical practice having different jobs is not, by itself, a red flag. But it tells you where things go. Start a billing complaint with Fountain. A clinical concern belongs with the treating practice; a licensing complaint belongs with the appropriate state medical or nursing board, depending on the clinician.

Dr. Stember's name is on it. He may not be your clinician.

Fountain identifies Dr. Doron Stember as its Chief Medical Officer and a board-certified urologist. Its biographies describe an NYU medical degree, a Mount Sinai urology residency, fellowship training at Memorial Sloan Kettering and Weill Cornell, and prior faculty work. Those are provider-stated credentials, not an independent board-certification or license check performed for this profile. Sources: current Fountain biography, older founder biography.

A medical director's name does not tell you who will conduct your visit. Fountain's terms allow care by different types of licensed professionals, and one reviewer describes seeing multiple nurse practitioners. Neither establishes your clinician assignment or the program's continuity policy. Sources: provider terms, Max's July 21 review.

Ask for your treating clinician's full name, professional role and license state, then check the appropriate state medical or nursing board. A corporate disclosure is not a license check, and neither is a founder's biography.

Fountain's older site also links to a LegitScript certification checker. We could not retrieve a current certification result from that checker, so we do not use certification as a verified trust badge here.

"24/7" describes the support team, not your clinician

Fountain's marketing promises around-the-clock concierge support and says replies typically arrive within about ten minutes. That's a provider-stated support claim, not a response time we tested. Source: Fountain program page.

The clinical layer reads differently. Duval Medical's own telehealth consent says telehealth services are available "8 hours a day, 5 days a week," while also describing typical daily provider availability for questions and scheduling. Source: telehealth consent.

Those statements do not establish one clear appointment or response guarantee. Fast texting is not the same as a clinician being available when you need one. If appointment access matters to you, ask what the current wait is for a first visit and what happens if a provider cancels.

The fine print that's easy to skip

The Terms of Use contain details worth reading before payment:

• Arbitration and a class-action waiver. The contract seeks to direct covered disputes to arbitration; applicability depends on the terms and law.
• A conditional $500 liability provision. The stated cap is a fallback if the preceding liability limits are unenforceable, not a universal statement that every possible medical claim is worth at most $500.
• De-identified data use. The terms permit certain uses and sales of de-identified or aggregated data. That is not the same as permission to sell identifiable medical records.
• Recording. The terms and telehealth consent describe recording visits for purposes such as quality review, subject to applicable law and consent.
• Payment disputes. The no-dispute clause is qualified by whether the transaction matches the terms. Do not read it as proof that an unauthorized or erroneous charge cannot be challenged.

How to request your medical records

Duval's consent gives a records-request contact: 1-833-967-3100 or support@fountain.net. It also describes online access to health information and possible reasonable costs for preparing and delivering copies. Ask for your visit notes, lab reports and medication record, and confirm any fee before ordering copies. Source: records-access provisions in the telehealth consent.

---

What testing should you expect — and is one blood draw enough?

Diagnosing low testosterone takes compatible symptoms or signs plus consistently low results, confirmed with appropriate repeat early-morning testing. Fountain describes blood testing before a video visit, but the public process does not establish whether a second diagnostic draw is routinely required or included. Ask how confirmation works before committing to treatment. Sources: Endocrine Society guideline, Fountain process.

Fountain's current process names Labcorp, concierge scheduling and an optional at-home collection upgrade. That is the provider's published process, not a lab appointment we tested; the Quest complaint above does not identify the lab you will use. Confirm the collection location and method for each required draw. Source: Fountain's evaluation process.

A few terms, in plain English

• Total testosterone — all the testosterone in your blood, bound and unbound. The main screening number.
• Free testosterone — the small fraction not bound to blood proteins. It can help clarify selected cases; it is not the only testosterone the body can use.
• SHBG (sex hormone-binding globulin) — the protein that holds testosterone. High SHBG can make total testosterone look fine while free testosterone is low.
• Hypogonadism — impaired testicular function, which can involve low testosterone, impaired sperm production, or both. This page concerns evaluation for testosterone deficiency.
• Hematocrit — the percentage of your blood made of red blood cells. Testosterone can push it up, so it gets monitored.
• PSA (prostate-specific antigen) — a prostate blood marker, monitored in some men on treatment.

Source for these terms and their clinical use: Endocrine Society full guideline.

What the specialty bodies actually say in 2026

The AUA uses total testosterone below 300 ng/dL as a reasonable cut-off that supports diagnosis, calls for two early-morning measurements on separate occasions, and requires symptoms or signs alongside the number. It is not a universal diagnosis or automatic prescription threshold. Sources: AUA guideline, FDA summary of diagnostic standards, PDF page 37 (slide 22).

The Endocrine Society reinforced this in a statement on July 16, 2026. Three points from it matter directly to anyone reading a TRT ad:

1. Diagnosis needs symptoms or signs plus consistently low, accurately measured testosterone. The full guideline calls for free testosterone when indicated, such as a borderline total result or a condition that changes SHBG—not a mandatory free-testosterone test for every man. The Society warns that terms like age-related and late-onset can blur disease and normal aging.
2. It does not support screening testosterone in men with no symptoms.
3. Where a clinician finds excess weight is the cause and excludes other causes, weight loss is typically the first-line treatment — the statement specifically discusses BMI above 27. BMI alone does not establish the cause.

Sources: July 16, 2026 statement, full diagnostic guideline.

That third point can change the next step from choosing a subscription to treating a reversible cause.

The Society also flags something practical: testosterone assays are not all standardized. The same blood sample can be classified differently depending on which lab ran it and how. Which is one more reason a single draw is a thin basis for potentially long-term treatment. Source: July 2026 statement.

A number you've probably seen, and where it comes from

Fountain markets a figure of up to 40% of men over 40 having low testosterone. Source: program page.

A frequently cited figure is 38.7%, from the Hypogonadism in Males study (Mulligan et al., International Journal of Clinical Practice, 2006). Fountain's page does not establish that this is the source of its claim. Here's what that study measured:

• Men aged 45 and older, not 40 and over
• Men already sitting in a primary care office — not the general population
• A single morning draw
• Classification based on total testosterone under 300 ng/dL or existing testosterone treatment, without requiring symptoms for that prevalence estimate
• An estimate from 2,162 men, including 80 already receiving testosterone

Source: HIM study abstract.

For contrast, the Boston Area Community Health Survey put symptomatic androgen deficiency at roughly 5.6% of men aged 30 to 79. Its population and definition differed, so the figures are not interchangeable. Source: Araujo et al., 2007.

A prevalence claim does not establish your personal likelihood of hypogonadism. You are not 40% likely to need testosterone treatment because you had a birthday.

Practical things to settle before your draw

• Ask for the right collection time. Diagnostic confirmation generally uses separate early-morning draws. Follow the ordering clinician's fasting and collection instructions; a later draw is not interchangeable with a properly timed diagnostic test.
• Ask what's on the panel besides testosterone — LH and FSH (pituitary signals), hematocrit, and PSA where appropriate.
• Ask who interprets the results and whether you get the actual lab report.
• Ask what ongoing monitoring looks like. The older Fountain site describes follow-up every three to six months; we did not verify that as the current schedule for every treatment. Ask for the first follow-up date, the tests required after starting or changing treatment, who reviews results, and who pays. Source: older program FAQ.
• Ask the clinician how cause-focused tests such as LH and FSH affect the next step. The cause can change the treatment discussion; do not interpret your own results from a table or one cutoff.

For the distinction between diagnostic and on-treatment tests, see our blood tests for TRT guide. Clinical source: Endocrine Society guideline.

There's a reason to care about all this beyond your own wallet. A study presented at ENDO 2026 found that only a small share of 200 men sampled at Michigan Medicine had received the complete diagnostic workup assessed by the researchers. This was not a study of Fountain or every U.S. clinic. Asking for the testing plan is useful; it does not by itself guarantee guideline-concordant care. Source: Endocrine Society's report of the study.

---

What medications does Fountain prescribe?

Fountain lists three possible treatment options: testosterone cypionate injections, a topical testosterone cream, and enclomiphene, with anastrozole and tadalafil as possible add-ons. Enclomiphene is not testosterone, and the public plan pages do not establish the exact product, strength or dispensing pharmacy for an individual patient. Confirm the actual prescription and any extra charge rather than assuming every treatment change leaves your bill unchanged. Source: Fountain's treatment list and plans.

Testosterone options: exact product still to be confirmed

A cream is not another name for an FDA-approved gel. An ingredient name alone does not establish approval of the dispensed product. Source: FDA on compounded drugs.

Non-testosterone option: enclomiphene

Sources: Fountain's advertised option, FDA's enclomiphene assessment, PDF pages 39–50.

"Topical cream" is a format, not a product

There's a real difference between an FDA-approved testosterone product — reviewed for safety, effectiveness and quality for its labeled uses — and a compounded preparation made to meet a patient's medical needs. Compounded drugs are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before marketing. A compounded preparation should not be presented as an approved generic, equivalent to an approved product, or safer simply because it is compounded. Source: FDA on compounded drugs.

We did not establish Fountain's exact cream or its pharmacy from the public pages checked. So ask, in writing: what is the product name, the strength, and which pharmacy dispenses it? If a seller won't answer that before taking your money, that's information too. Public-page silence is not proof that Fountain refuses to answer before payment.

One more thing that matters with skin-applied testosterone: testosterone can transfer to other people through skin contact. If you have young children or share close contact with a partner, ask about application site, cover-up and washing instructions before you choose that format. Follow the instructions for your actual product; do not borrow another product's application rules. Source: AndroGel's secondary-exposure warning. For the broader distinction, see TRT treatment formats.

Enclomiphene is not testosterone — and Fountain's own page blurs it

On Fountain's TRT page, the body copy refers to an oral testosterone treatment. The treatment list on that same page says: injections, cream, enclomiphene. That wording does not make enclomiphene testosterone. Source: Fountain's program page.

Enclomiphene is not testosterone. It's a selective estrogen receptor modulator — it nudges your own pituitary gland to signal for more testosterone rather than supplying the hormone directly. Four things follow from that, and they're the kind of thing you want to know before, not after:

1. Stand-alone enclomiphene has no FDA approval for any indication. A compounded preparation does not become FDA-approved because a clinician prescribes it. It should never be called "oral TRT."
2. Clomiphene and enclomiphene do not have the same approval status. Clomiphene is an FDA-approved drug for certain ovulation problems in women; its use for male testosterone deficiency is off-label. Enclomiphene is one component of clomiphene, not an approved stand-alone drug being used off-label.
3. The cause of low testosterone matters. Stimulating hormone signals is not a substitute for testosterone in every form of testicular disease. A clinician must assess the cause; a higher blood-test number alone does not establish symptom benefit.
4. Athletes and service members need a separate rules check. The Department of Defense's Operation Supplement Safety program identifies both drugs as prohibited in tested sport and as prohibited dietary-supplement ingredients. That is not a blanket ban on every prescribed military use. Service members should check with their military clinician; athletes should check their governing body's rules and any therapeutic-use exemption before taking a medicine.

Sources: FDA's enclomiphene review, PDF pages 39–50; Operation Supplement Safety, updated January 12, 2026.

And the one that matters most: enclomiphene is not a fertility guarantee. It is often discussed in the context of preserving sperm production, but nobody — not us, not a telehealth program — can promise you that. If children are a near-term plan, that conversation belongs with a urologist or reproductive urologist before you start anything. Sources: FDA's evidence review, Endocrine Society fertility guidance. See our TRT and fertility guide.

What changed on testosterone labeling in 2026

Older reviews may miss two federal actions. The dates and the difference between a requested change and a finished product label matter:

February 28, 2025 — the FDA announced class-wide labeling changes: removal of boxed-warning language about increased cardiovascular risk following the TRAVERSE trial, and new or updated warnings about increased blood pressure across the class. This did not mean testosterone had become risk-free. Source: FDA announcement.

June 18, 2026 — HHS and the FDA requested further class-wide updates: removing the long-standing "limitation of use" saying safety and effectiveness in men with age-related low testosterone hadn't been established, updating prostate cancer risk information, and revising the warnings on enlarged prostate (BPH). Source: HHS/FDA request.

Two cautions on that second one. A request is not a finished label — check the current prescribing information for whatever you're actually given. The Endocrine Society's July statement reinforces diagnostic standards; it does not establish a newly tightened diagnosis or turn the FDA request into permission to treat normal aging. Label changes do not diagnose you. Source: Endocrine Society's July 16, 2026 statement.

Worth knowing on the other side of the ledger: TRAVERSE found similar rates of its main combined cardiovascular outcome in the testosterone and placebo groups, but pulmonary embolism — blood clots in the lungs — was reported in 0.9% versus 0.5%. That is a difference of about 4 people per 1,000, calculated from the rounded reported rates. These were trial-event rates over an average 33 months of follow-up, not annual risk estimates. The trial studied men aged 45–80 with symptoms, confirmed low testosterone and existing or high cardiovascular risk, using a specific testosterone gel; it was not a trial of Fountain or every compounded preparation. Source: the trial investigators' report.

It's a real signal, and it's a fair thing to raise with your clinician. Blood-pressure monitoring addresses the separate pressure-increase concern identified by the FDA; blood-count monitoring addresses the rise in red blood cells that testosterone can cause. Neither is proof that clot risk has been cleared. Sources: FDA labeling action, Endocrine Society monitoring guidance.

---

Is Fountain available in your state, and does it take insurance?

We did not verify a complete current list of the states Fountain serves. Fountain describes its program as cash-pay and does not bill insurance; neither a general website nor an HSA/FSA card establishes your individual coverage or eligibility. Confirm care for the state where you will physically be during the visit and check any reimbursement or tax-account question with your plan. Sources: Fountain's terms, telehealth consent.

Why we won't hand you a state list

The older fountaintrt.com site names twenty states. We're not reproducing it as a current coverage map, because we did not verify that it is complete and current. Source: older program FAQ.

Fountain's telehealth consent carries state-specific notices for Alaska, California, Iowa, Indiana, Kentucky, Maine, Oregon, Rhode Island, Texas and Vermont — and seven of those don't appear on the twenty-state list at all. We can't tell you that's a service map either; those notices can be template language. Different lists do not prove a contradiction in actual coverage: a legal notice is not a promise that a clinician is available in that state. Sources: older state list, consent's state notices.

Ask Fountain to confirm your state before paying. Confirm the state where you'll actually be located during care, not just where you were born or where your card is registered. We did not test the intake or verify that a ZIP-code entry gives a definitive availability answer.

The insurance answer, straight

No insurance billing. Fountain's terms say it isn't enrolled with any third-party payer, including Medicare and Medicaid, and that you're choosing care on a cash basis. It will provide an itemized bill on request that you may submit to a payer yourself — whether anything comes back is entirely between you and your plan. Source: Fountain's payment terms.

There's a tradeoff hiding in that, and it cuts both ways. Fountain's membership is not waiting for an insurer to approve its bill. It also means the full amount is yours unless your plan separately agrees to reimburse an eligible expense. That does not establish coverage for outside labs or medications.

The lab question is the one to nail down

Fountain says membership includes required lab monitoring — then adds, in its own footnote, "except where prohibited by state law."

That carve-out is real, but the public pages checked do not identify all affected states, the applicable fees, or how the exception works for a particular member. Robert Morie reported getting a $168 bill from Quest after expecting the evaluation price to cover the testing. His report does not establish that a state-law exception caused the bill. Sources: Fountain's inclusion statement, Morie's July 8 review.

So: ask which lab you'll use, and whether the draw and the panel will be billed to you separately in your state. Get the answer in writing. This closes a specific billing gap; it does not predict whether you'll be satisfied with the care.

One rule that could change things in 2027

Testosterone is a Schedule III controlled substance in the United States. It requires a valid prescription. Source: DEA drug scheduling.

One current federal path for prescribing controlled medication without a prior in-person examination is a temporary telemedicine flexibility. On December 31, 2025, the DEA and HHS issued a fourth temporary extension running January 1 through December 31, 2026. For testosterone, that path requires an appropriate audio-video encounter and compliance with the rule's conditions, other federal requirements and state law; other statutory telemedicine exceptions also exist. It is not a questionnaire-only prescription guarantee. Source: the fourth temporary extension.

Don't panic — it's been extended four times. But another extension is not guaranteed, and a 48-week plan bought now runs into 2027. It's a fair thing to ask about: what happens to my plan if federal telemedicine rules change mid-term? Worth noting alongside it: Duval Medical's consent states the practice has no in-person clinic locations. Ask how it handles a required examination, a local-care referral, interrupted refills and any unused prepaid balance. Sources: current federal extension, Duval's consent.

Not sure your state, your budget and your fertility plans point to online care at all? That's four questions in a trench coat, and a review page can't answer them for you. → Map the care route that fits your situation with Find My TRT Path (free, educational, non-diagnostic)

---

Who should choose a different route — and what would we look at instead?

Fountain can suit a man who wants a bundled cash-pay program and a video visit, with cream among the advertised treatment options. A different care route makes sense when fertility needs, insurance, a specific FDA-approved product, or a complex health issue cannot be served by the confirmed offer. Without a proper diagnosis, the next step is an evaluation — not a prepaid treatment commitment. Sources: Fountain's program, Endocrine Society guidance.

The honest limitation

Fountain's public plan pages do not identify the exact product and pharmacy you would receive. We did not establish the patient-specific product name or strength, either. That is a real disclosure gap, not proof that Fountain will withhold an answer before payment. Ask first; a written answer can resolve it. Source: public plan page checked.

For a more detailed public price card, Male Excel publishes more of the formulation and pricing basis — testosterone cypionate injections or a Lipoderm cream, starting amounts, billing terms and a plain statement that testosterone is a Schedule III medication requiring monitoring. Its FAQ names AnazaoHealth and WellDyneRx as pharmacy partners and describes its cream as compounded. Those are provider disclosures, not our verification of your eventual prescription or those pharmacies' current licenses. Sources: Male Excel's pricing page, FAQ.

That does not make Male Excel the answer for someone who requires an FDA-approved product. Its compounded cream is not an FDA-approved alternative to a manufactured gel. For that priority, ask a prescriber and pharmacy to confirm a specific approved product; for insurance, start with an in-network care route. Source: FDA's compounding distinction.

But understand the trade. Fountain publishes a bundled base plan; Male Excel charges a required membership fee plus medication. Fountain's inclusion statement covers provider visits, medication and shipping, with a state-law exception for monitoring labs. That can make the base bill easier to compare, but it does not prove every add-on or future prescription change is free. Fountain's terms also allow price changes. You're comparing two billing models, not buying a promise that a bill can never move. Sources: Fountain's inclusions, terms, Male Excel's pricing.

What a year costs at each, side by side

Read from each provider's own live pricing and policy pages on September 14, 2026. Male Excel is a commercial partner; the links here are direct public-information links. That does not change the arithmetic.

Sources: Fountain plans, inclusions, refund policy; Male Excel pricing, FAQ, membership-guarantee terms.

The $2,727 calculation is $99 + (12 × $99) + (12 × $120). The $2,871 calculation substitutes $132 for the medication rate. Both exclude shipping, price changes, dose-dependent costs and any separately billed testing. They assume six two-month medication payments; they are not verified checkout totals.

Male Excel's cards also advertise FSA/HSA eligibility; confirm the actual expense with your plan. Its separate 90-day guarantee requires eligible new members to meet the program conditions and request a refund within 30 days after the 90-day period; it covers initial membership fees, not the medication or consultation. Sources: pricing cards, guarantee terms.

The same calendar issue deserves attention at Male Excel. Its page uses both 60-day supply and every other month. Those are not identical intervals. If a two-month supply costs $240 for injections or $264 for cream and renewal is exactly every 60 days starting on day 0, seven medication charges fall before day 365. With 12 membership payments and the $99 consultation, that conditional cash model is $2,967 or $3,135, before the same extras. Ask which schedule is in the actual agreement rather than assuming either model is the one you will pay.

Two things we'll say out loud because they're true.

Fountain's normalized base-plan figures are lower than Male Excel's displayed starting-rate models — and Male Excel is our commercial partner. That is a base-price finding, not proof of a cheaper complete first year for every person. Missing evaluation, lab, shipping and prescription-specific amounts prevent a verified all-in ranking.

And Male Excel has rough edges of its own. Its pricing page currently shows its oral product at both $95 and $120 in different places on the same page. And thyroid medication appears in each of the three displayed hormone-treatment bundles — so before you enroll, ask whether the thyroid component is optional and what diagnosis and labs support prescribing it. You're being quoted for more than testosterone alone. Source: Male Excel pricing page.

That oral product, Triclozene, is listed as a clomiphene-containing compound, not testosterone replacement. Do not compare it with testosterone injections as though the medicines are interchangeable. The page's ingredient list is not proof that the finished compound is FDA-approved. Sources: Male Excel's ingredient list, FDA on compounded drugs.

If you're this, do that

These are editorial care-route judgments based on the evidence above. For a route rather than another subscription, compare online versus local TRT care. For the comparator's full details, see our Male Excel profile and cost breakdown.

Disclosure: Male Excel is a commercial partner of TRT Provider Guide. This is a direct public-information link, not an affiliate enrollment link. See our affiliate disclosure and How We Review TRT Providers.

Need to compare the published formulation details and required membership fee? → See Male Excel's current pricing and program requirements

---

What should you ask Fountain before you pay?

Before paying, get a written answer on the lab bill, prescription, repeat testing, refund and renewal dates. Those answers should describe your state and the actual plan, not just repeat a general price card.

Five questions. One message. Send them before your card is entered, and keep the reply.

1. "Which lab will I use, and will the draw and the panel be billed to me separately in my state?"
2. "What is the exact medication name and strength, and which pharmacy dispenses it?"
3. "Will my prescription be based on one morning blood test or two?"
4. "If I prepay the 48-week plan and cancel in month three, exactly what is refunded and how is it calculated?"
5. "What is my first charge date, my renewal date, and the renewal amount — in writing?"

For the billing questions, start with 1 and 4. Do not skip the product and testing questions before treatment; a clear invoice is not the whole decision.

And keep a copy of the reply. A plan card on a website is not your billing agreement.

---

How did we check this?

This is a documents-and-pricing profile, not a hands-on review, and we won't call it one. We didn't become a patient, we weren't given an account, and the Fountain links here are ordinary information links, not affiliate referrals.

We checked Fountain's public pages and legal documents, the first two pages of its Trustpilot profile, Male Excel's published pricing and policies, and accessible primary medical and regulatory sources on September 14, 2026. The AUA standard was cross-checked against its description in the FDA's evidence review and the accessible Endocrine Society guideline; this was not a complete read of the AUA website. Every cost figure labeled as ours is arithmetic on the published plan terms, with the assumptions stated so you can redo it.

We keep four kinds of statement separate throughout: verified fact (such as a recalculated total or an official rule), provider-stated fact (a service promise or policy published by the provider, not proof of delivery), customer-experience signal (an individual, attributable report — never proof of typical results), and our editorial judgment (a conclusion drawn from the first three).

We don't score providers out of five. A single number hides the only thing that matters: which parts fit you. Our full method is at How We Review TRT Providers.

Prices, policies and rules change. If you find something here that's out of date, tell us through our corrections page and we'll check it and update the verification date. Our editorial standards explain the source rules. Read our privacy policy before sharing personal information with our tools.

---

What else should you know about Fountain TRT reviews?

The remaining questions are about what the advertised plan does not settle for you. A published policy, a customer review and your own written quote answer different things.

Is Fountain TRT legit? Fountain publishes an identifiable operating company, named medical-practice partners and a blood-test/video-visit process. That supports an identifiable telehealth offering, not a guarantee of clinical quality or a completed license audit. We did not independently confirm current LegitScript certification through its issuer. Sources: Fountain's terms, program, LegitScript's website checker.

How much does Fountain TRT cost per month? There isn't a calendar-month price in the current plan cards. Fountain bills in four-week blocks: $199 every 4 weeks, $499 every 12 weeks, or $1,799 every 48 weeks. That works out to $199, $166.33 and $149.92 per four-week cycle. Source: current plans.

Why does a year cost more than twelve times $199? Because thirteen four-week cycles are 364 days, not twelve calendar months. Thirteen Starter cycles cost $2,587. With the first charge on day 0 and uninterrupted 28-day renewal, a fourteenth charge lands on day 364, bringing the cash total before day 365 to $2,786. That is the model above, excluding the evaluation and any separate fees.

Which plan actually costs the least in year one? It depends which question you're asking. Pro has the lowest weekly rate, about $37.48, and the lowest normalized 365-day base cost, $1,954.27. In the uninterrupted-renewal model, its day-336 renewal brings cash paid to $3,598, while Standard has the lowest cash requirement at $2,495. None of those amounts is a verified all-in patient quote.

Does Fountain TRT include blood work? Fountain says membership includes required lab monitoring, subject to a state-law exception. We did not establish which states incur extra charges or whether every needed repeat diagnostic test is included. Confirm the draw, panel, repeat testing and billing responsibility in writing for your state. Source: Fountain's membership inclusions.

Can I cancel Fountain TRT any time? Fountain's published terms allow cancellation by text or email, with account closure at the end of the current billing period. Ask for written confirmation that renewal has stopped; cancelling isn't the same as requesting a refund. We did not test the cancellation process. Sources: terms, Return Policy.

Can I get a refund if I prepaid for 48 weeks? Under the Return Policy linked from fountain.net, delivered treatment and shipped medication generally aren't refundable, but a prepaid balance covering future months can be refunded pro rata when you cancel. An older Fountain page still says services and medication are not refundable even if unused. Get the applicable term, eligible amount and calculation confirmed in writing before prepaying. Sources: Return Policy, older terms.

Is the initial Fountain evaluation still $35? We couldn't confirm the current amount from the public Fountain pages checked. A reviewer reported a $35 expectation, but don't treat a review as a live quote — check the amount, any separate lab charge and what the evaluation guarantee covers at checkout. Sources: Fountain's guarantee wording, Robert Morie's July 8 report.

What states is Fountain TRT available in? We did not verify a complete current list. The older site's twenty-state list and the consent's state-specific legal notices are different types of information; the notices do not prove coverage. Ask Fountain to confirm care where you will physically be during the visit. Sources: older FAQ, telehealth consent.

Does Fountain TRT take insurance? No. It's cash-pay and its terms state it isn't enrolled with any third-party payer, including Medicare and Medicaid. It will provide an itemized bill on request that you can submit to your plan yourself; whether anything is reimbursed depends entirely on your coverage. Source: payment terms.

Does Fountain prescribe injections or cream? Fountain lists both testosterone cypionate injections and topical testosterone cream. It separately lists enclomiphene, which is not testosterone. Ask for your exact product, strength, dispensing pharmacy and price; shared plan cards do not prove every add-on or prescription change is free. Source: Fountain's treatment list.

Is Fountain's testosterone cream FDA-approved? We did not identify the exact cream dispensed to a patient from Fountain's public pages. Compounded preparations are not FDA-approved and should not be treated as equivalent to approved products. Ask for the product name, strength and pharmacy before you decide. Source: FDA on compounded drugs.

Is enclomiphene the same as TRT? No. Enclomiphene is a selective estrogen receptor modulator that can stimulate the body's own testosterone production. It isn't testosterone, has no FDA approval as a stand-alone drug, and should never be described as oral TRT or promised as a way to protect fertility. Source: FDA's enclomiphene assessment, PDF pages 39–50.

Will TRT affect my fertility? Testosterone taken from outside the body can suppress sperm production. Nobody can promise what will happen in your case, in either direction. If children are a near-term plan, talk to a urologist or reproductive urologist before starting anything. Source: Endocrine Society guideline.

Does completing the assessment guarantee a prescription? No. Fountain's consent reserves treatment and prescribing decisions to the clinician. An assessment or single result does not establish a diagnosis, clinical eligibility or a guaranteed prescription. Source: telehealth consent.

Can I use my own pharmacy? Fountain's terms and consent both state that if a prescription is written, you may direct it to the pharmacy of your choice. That doesn't make the membership free, and it may change how the plan works — ask how choosing an outside pharmacy affects your medication charge and fulfillment. Sources: terms, consent.

When do refills ship, and what happens if one is late? Fountain advertises two-day shipping, but does not establish the total time from payment through prescribing, pharmacy processing and delivery. That claim is not a complete refill schedule. Confirm how much medication each shipment covers, the refill cutoff, required labs, and who handles a delay; billing every 12 or 48 weeks does not establish how often shipments leave. Contact the care team and prescriber about an interruption rather than changing treatment yourself. Source: Fountain's process description.

How can I get my medical records? Duval's consent directs records requests to 1-833-967-3100 or support@fountain.net and allows for a reasonable copying fee. Ask for lab reports, visit notes and the medication history, as well as the timing and any fee. Source: records-access paragraph in the consent.

---

Educational information, not medical advice. This page does not diagnose low testosterone, determine eligibility, or replace a clinician. Testosterone is a Schedule III controlled substance and requires a valid prescription. If you have chest pain, shortness of breath, sudden severe headache, or vision changes, seek urgent or emergency care now.

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

---

Sources

Fountain's own pages, all read September 14, 2026: fountain.net · fountain.net/trt · Terms of Use (updated April 3, 2024) · Return Policy (updated April 3, 2024) · Telehealth Consent (updated July 24, 2024) · fountaintrt.com and its terms page

Comparator: Male Excel hormone treatment costs, FAQ and membership-guarantee terms, checked September 14, 2026.

Customer experience: Trustpilot — FountainTRT and page 2, 316-review profile snapshot on September 14, 2026. Individual reports, not a census of patients or an audit of outcomes.

Primary medical and regulatory sources:

• FDA, class-wide labeling changes for testosterone products, February 28, 2025
• HHS/FDA, requested updates to testosterone therapy product labels, June 18, 2026
• DEA and HHS, Fourth Temporary Extension of telemedicine flexibilities, December 31, 2025 — in effect January 1 through December 31, 2026; HHS summary.
• American Urological Association, Testosterone Deficiency Guideline. The diagnostic standard was cross-checked through FDA's 2022 evidence review, PDF page 37 (slide 22); the AUA page was not fully accessible during this check.
• Endocrine Society, Statement on Testosterone Replacement Therapy, July 16, 2026
• Mulligan T, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762–769.
• Lincoff AM, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389:107–117. Trial population and absolute event rates checked against the investigators' Cleveland Clinic report.
• Endocrine Society, Testosterone Therapy in Men With Hypogonadism guideline, 2018; recommendation summary.
• Araujo AB, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92:4241–4247.
• Endocrine Society, ENDO 2026 report on diagnostic testing at Michigan Medicine, June 13, 2026.
• FDA, Compounded-drug risks and 2022 enclomiphene evidence assessment, PDF pages 39–50.
• Operation Supplement Safety, Clomiphene and enclomiphene: drugs, not dietary supplements, updated January 12, 2026.
• DEA, Drug scheduling.
• AndroGel, secondary-exposure safety information and prescribing-information links.